Suzanne Coberly
Senior Director - Translational Pathology Bristol Myers Squibb
Seminars
Wednesday 25th March 2026
Translating Precision Biomarkers into Clinical Trials with AI and Digital Pathology
4:15 pm
- Advancing translational biomarker discovery by integrating novel assays with AI-driven image analysis to bridge preclinical findings into proof-of-concept clinical testing.
- Leveraging virtual IHC to increase efficiency in clinical trial biomarker evaluation by using H&E-based screening to rapidly identify the most informative biomarkers for PD/MoA studies and patient stratification.
- Confirming and refining biomarkers for clinical use through targeted mIF/IHC validation of the top candidates, enabling the development of robust, trial-ready clinical assays.
